The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%.

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

Prescription weight loss medication has become extremely ... healthcare professional before taking any weight loss medication. Medical News Today has strict sourcing guidelines and relies on ...

Popular weight-loss drugs like Wegovy and Zepbound are boosting the use of healthcare in the U.S., leading to an uptick in ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...